当前位置: X-MOL 学术Mol. Ther. Methods Clin. Dev. › 论文详情
A DNA vaccine that encodes an antigen presenting cell-specific heterodimeric protein protects against cancer and influenza
Molecular Therapy - Methods & Clinical Development ( IF 4.875 ) Pub Date : 2020-01-25 , DOI: 10.1016/j.omtm.2020.01.007
Ranveig Braathen; Heidi Cecilie Larsen Spång; Daniëla Maria Hinke; Jana Blazevski; Sonja Bobic; Even Fossum; Bjarne Bogen

Immunogenicity of DNA vaccines can be increased by constructing the DNA in such a way that it encodes secreted homodimeric fusion proteins that target antigen presenting cells (APC). We have here developed novel APC-targeting vaccine molecules with an increased flexibility due to introduction of a heterodimerization motif. The heterodimeric proteins permit four different fusions within a single molecule, thus allowing expression of two different APC-targeting moieties and two different antigens. Two types of heterodimeric fusion proteins were developed that employed either the ACID/BASE- or the Barnase/Barstar-motifs, respectively. The ACID/BASE heterodimeric vaccines conferred protection against challenges with either influenza virus or tumor cells in separate preclinical models. The ACID/BASE-motif was flexible since a large number of different targeting moieties and antigens could be introduced with maintenance of specificity, antigenicity and secretion. APC-targeting ACID/BASE vaccines expressing two different antigens induced antibody and T cell responses against either of the two antigens. Heterodimeric ACID/BASE DNA vaccines were of approximately the same potency as previously reported homodimeric DNA vaccines. The flexibility and potency of the ACID/BASE format suggest that it could be a useful platform for DNA vaccines that encode APC-targeting fusion proteins.
更新日期:2020-01-26

 

全部期刊列表>>
化学/材料学中国作者研究精选
Springer Nature 2019高下载量文章和章节
《科学报告》最新环境科学研究
ACS材料视界
自然科研论文编辑服务
中南大学国家杰青杨华明
剑桥大学-
中国科学院大学化学科学学院
材料化学和生物传感方向博士后招聘
课题组网站
X-MOL
北京大学分子工程苏南研究院
华东师范大学分子机器及功能材料
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug